-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, IRgjpaBsFcEzGwDtLhkKKQELN4dDV5W2ZDhYg6M95BZeOXVZLb7T1L1haIZux4p0 K85o981WHjeZu92UxkF4Gw== 0001181176-04-000003.txt : 20040630 0001181176-04-000003.hdr.sgml : 20040630 20040630105315 ACCESSION NUMBER: 0001181176-04-000003 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20040629 FILED AS OF DATE: 20040630 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GILMARTIN RAYMOND V CENTRAL INDEX KEY: 0001181176 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-03305 FILM NUMBER: 04890300 BUSINESS ADDRESS: STREET 1: MERCK & CO INC STREET 2: ONE MERCK DR PO BOX 100 CITY: WHITEHOUSE STATION STATE: NJ ZIP: 08889 BUSINESS PHONE: 9084231000 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MERCK & CO INC CENTRAL INDEX KEY: 0000064978 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 221109110 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE MERCK DR STREET 2: P O BOX 100 CITY: WHITEHOUSE STATION STATE: NJ ZIP: 08889-0100 BUSINESS PHONE: 9084234044 MAIL ADDRESS: STREET 1: ONE MERCK DR STREET 2: PO BOX 100 WS3AB-05 CITY: WHITEHOUSE STATION STATE: NJ ZIP: 08889-0100 4 1 gil428.xml X0202 4 2004-06-29 0 0000064978 MERCK & CO INC (MRK) 0001181176 GILMARTIN RAYMOND V ONE MERCK DRIVE WHITEHOUSE STATION NJ 088890100 1 1 0 0 COB, President & CEO Phantom Stock 0.0000 2004-06-29 4 A 0 1108.7645 47.3500 A Common Stock 1108.7645 113910.9457 D 1-for-1 The Merck Deferral Program includes the right of redesignation to other investment measures within the Program. Distributions of phantom stock are made in shares of Merck Common Stock, with cash payable for partial shares, in accordance with a distribution schedule elected by the reporting person. This distribution is subject to conditions and limitations of the Merck Deferral Program. Holdings include shares acquired in dividend reinvestment transactions. By: Nancy V. Van Allen as Attorney-in-Fact for 2004-06-30 -----END PRIVACY-ENHANCED MESSAGE-----